ADAP
Adaptimmune Therapeutics
ADAP
ADAP
62 hedge funds and large institutions have $27.7M invested in Adaptimmune Therapeutics in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 11 closing their positions.
Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
8
Reduced
19
Closed
11
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$11K